Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Enhancing Therapy Adherence Among Metastatic Breast Cancer Patients: the Study Protocol

NCT06161181 is registered in ClinicalTrials.gov with European Institute of Oncology as lead sponsor.

NCT NCT06161181
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06161181 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Enhancing Therapy Adherence Among Metastatic Breast Cancer Patients: the Study Protocol
Lead sponsor
European Institute of Oncology
Phase
Not applicable
Overall status
Completed
Start date
May 3, 2023
Completion date
May 15, 2024
Enrollment
94 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic breast cancer